Syntax Bio
Syntax Bio’s regenerative medicine discovery platform overcomes the longstanding challenges in stem cell derived therapies by directly controlling and accelerating cell differentiation. A shorter and more reliable iPSC differentiation process improves patient access by making stem cell discovery and manufacturing faster, less costly and scalable. Synatx’s proprietary Cellgorithm technology mimics human development using a sequential synthetic biology CRISPR based system to generate a wide diversity of functional cell types to enable new cell and gene therapy product opportunities.
